WebPear owns Somryst, a digital sleep behavioral program. Digital health can a be a tough gig. #sleep #insomnia Web"Pear Therapeutics files for bankruptcy" - A major set back for the advancement of digital therapeutics. First, want to thank Pear Therapeutics team for… Niyati Parikh on LinkedIn: #peartherapeutics #digitaltherapeutics #digitalmedicine
Pear Therapeutics Announces FDA Submission for Somryst
WebApr 13, 2024 · Pear Therapeutics, Inc. (NASDAQ:PEAR – Get Rating) major shareholder 5Am Partners Iv, Llc sold 16,544,113 shares of the stock in a transaction on Monday, April 10th. The stock was sold at an ... WebApr 13, 2024 · 光看产品的话，作为行业龙头，Pear公司的管线很是丰富。 针对药物使用障碍的reSET、阿片类药物使用障碍的reSET-O，以及慢性失眠的Somryst三款产品均已获批上市 ，另有14个产品在研，涵盖精神病学、神经病学、胃肠、肿瘤学、心血管等多个领域。. 2024年，Pear公司实现420.8万美元的收入，其中产品销售 ... higher tents
LinkedIn Emanuela Offidani, PhD 페이지: Pear Therapeutics Files …
WebApr 12, 2024 · s promising area. As you probably know, Pear Therapeutics has recently declared bankruptcy, leading to significant job losses.With applications like reSET, reSET-O, and Somryst, which address substance use disorder, opioid use disorder, and sleeplessness, the business was at the vanguard of PDT development. WebNov 23, 2024 · Post-marketing studies are ongoing to evaluate the performance of Somryst for patients with chronic insomnia in natural, or community settings. A virtual, open-label, … WebApr 14, 2024 · Pear Therapeutics, Inc. (NASDAQ:PEAR – Get Rating) major shareholder 5Am Partners Iv, Llc sold 16,544,113 shares of the business’s stock in a transaction that … higher terms